Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015Dec 10, 2018HiFiBiO Therapeutics and Vikas Sukhatme Join Forces to Discover and Develop Novel Antibody Treatments for CancerOct 15, 2018HiFiBiO Therapeutics Acquires H-Immune TherapeuticsOct 2, 2018Research Collaboration to Develop Technology for the Treatment of CancerJul 30, 2018HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with TakedaMay 16, 2018HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders< 1 … 12 13 14 15 16 17 >
